These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

4199 related articles for article (PubMed ID: 6854056)

  • 1. The chemotherapy of malignant melanoma.
    Wick MM
    J Invest Dermatol; 1983 Jun; 80 Suppl():61s-62s. PubMed ID: 6854056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The chemotherapy of malignant melanoma.
    Wick MM
    J Invest Dermatol; 1983 Jun; 80(1 Suppl):61s-2s. PubMed ID: 20479737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic effect of dopamine infusion on human malignant melanoma.
    Wick MM
    Cancer Treat Rep; 1982 Aug; 66(8):1657-9. PubMed ID: 7105057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of L-dopa and carbidopa in metastatic malignant melanoma.
    Gurney H; Coates A; Kefford R
    J Invest Dermatol; 1991 Jan; 96(1):85-7. PubMed ID: 1987300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levodopa + carbidopa + entacapone. Entacapone: a second look: new preparations. Parkinson's disease: a modest effect.
    Prescrire Int; 2005 Apr; 14(76):51-4. PubMed ID: 15875340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary influence of tyrosine and phenylalanine on the response of B16 melanoma to carbidopa-levodopa methyl ester chemotherapy.
    Meadows GG; Pierson HF; Abdallah RM; Desai PR
    Cancer Res; 1982 Aug; 42(8):3056-63. PubMed ID: 7093952
    [No Abstract]   [Full Text] [Related]  

  • 7. A Phase II trial of vinorelbine tartrate in patients with disseminated malignant melanoma and one prior systemic therapy: a Southwest Oncology Group study.
    Whitehead RP; Moon J; McCachren SS; Hersh EM; Samlowski WE; Beck JT; Tchekmedyian NS; Sondak VK;
    Cancer; 2004 Apr; 100(8):1699-704. PubMed ID: 15073859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levodopa and dopamine analogs: dihydroxy and trihydroxybenzylamines as novel quinol antitumor agents in experimental leukemia in vivo.
    Wick MM
    Cancer Treat Rep; 1981; 65(9-10):861-7. PubMed ID: 7273019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levodopa and dopamine analogs as DNA polymerase inhibitors and antitumor agents in human melanoma.
    Wick MM
    Cancer Res; 1980 May; 40(5):1414-8. PubMed ID: 6768447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II study of biweekly plitidepsin as second-line therapy in patients with advanced malignant melanoma.
    Eisen T; Thomas J; Miller WH; Gore M; Wolter P; Kavan P; Martín JA; Lardelli P
    Melanoma Res; 2009 Jun; 19(3):185-92. PubMed ID: 19436178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pilot study of high-dose, concurrent biochemotherapy for advanced melanoma.
    Kim KB; Eton O; East MJ; Hodges C; Papadopoulos NE; Grimm EA; Bedikian AY
    Cancer; 2004 Aug; 101(3):596-603. PubMed ID: 15274073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II study of weekly Kahalalide F in patients with advanced malignant melanoma.
    Martín-Algarra S; Espinosa E; Rubió J; López López JJ; Manzano JL; Carrión LA; Plazaola A; Tanovic A; Paz-Ares L
    Eur J Cancer; 2009 Mar; 45(5):732-5. PubMed ID: 19186051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of transformation by levodopa-carbidopa in lymphocytes derived from patients with melanoma.
    Wick MM
    J Invest Dermatol; 1987 May; 88(5):535-7. PubMed ID: 3572025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chemotherapy of malignant melanoma].
    Ishihara K; Yamazaki N; Asano K
    Gan To Kagaku Ryoho; 1993 Aug; 20(10):1287-92. PubMed ID: 7688498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A combination chemotherapy of ACNU and DTIC for advanced malignant melanoma].
    Domyo M; Ogawa M; Inagaki J; Horikoshi N; Ezaki K; Inoue K; Aiba K; Nagata T; Miyamoto H
    Gan To Kagaku Ryoho; 1982 May; 9(5):874-9. PubMed ID: 6964041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of therapy on the antioxidant status in patients with melanoma.
    Gadjeva V; Dimov A; Georgieva N
    J Clin Pharm Ther; 2008 Apr; 33(2):179-85. PubMed ID: 18315784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of standard carbidopa-levodopa and sustained-release carbidopa-levodopa in Parkinson's disease: pharmacokinetic and quality-of-life measures.
    Pahwa R; Lyons K; McGuire D; Silverstein P; Zwiebel F; Robischon M; Koller WC
    Mov Disord; 1997 Sep; 12(5):677-81. PubMed ID: 9380047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose platinum combination therapy in pretreated patients with disseminated melanoma.
    Hofmann MA; Gabriel V; Milling A; Kiecker F; Sterry W; Trefzer U
    Chemotherapy; 2007; 53(6):422-8. PubMed ID: 17952002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A human melanoma xenograft in a nude rat responds to isolated limb perfusion with TNF plus melphalan.
    Bauer TW; Gutierrez M; Dudrick DJ; Li J; Blair IA; Menon C; Fraker DL
    Surgery; 2003 Apr; 133(4):420-8. PubMed ID: 12717360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levodopa/dopamine analogs as inhibitors of DNA synthesis in human melanoma cells.
    Wick MM
    J Invest Dermatol; 1989 May; 92(5 Suppl):329S-331S. PubMed ID: 2715667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 210.